Format

Send to

Choose Destination
Bioresour Technol. 2006 Aug;97(12):1372-6. Epub 2005 Aug 19.

Antiplatelet property of Curcuma longa L. rhizome-derived ar-turmerone.

Author information

1
Faculty of Applied Biotechnology, Research Center for Industrial Development of Biofood Materials, College of Agriculture, Chonbuk National University, Chonju 561-756, Republic of Korea. hoiseon@chonbuk.ac.kr

Abstract

The antiplatelet activities of Curcuma longa L. rhizome-derived materials were measured using a platelet aggregometer and compared with those of aspirin as antiplatelet agent. The active constituent from the rhizome of Curcuma longa L. was isolated and characterized as ar-turmerone by various spectral analyses. At 50% inhibitory concentration (IC50) value, ar-turmerone was effective in inhibiting platelet aggregation induced by collagen (IC50, 14.4 microM) and arachidonic acid (IC50, 43.6 microM). However, ar-turmerone had no effect on platelet activating factor or thrombin induced platelet aggregation. In comparison, ar-turmerone was significantly more potent platelet inhibitor than aspirin against platelet aggregation induced by collagen. These results suggested that ar-turmerone could be useful as a lead compound for inhibiting platelet aggregation induced by collagen and arachidonic acid.

PMID:
16112857
DOI:
10.1016/j.biortech.2005.07.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center